Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Researchers need your help. By taking part in research studies and clinical trials, you will help them make progress to improve lives and find a cure for type 1 diabetes.
Our ambitious new roadmap is aimed at driving significant advancements in type 1 diabetes research, treatment, and care.
Your donation helps support people living with type 1 diabetes and funds the best treatment and cure research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
Home > News & events > News > New study looks at gut bacteria and type 1 diabetes risk
The study, published in Nature Metabolism, analysed stool samples from 887 children with a high genetic risk of T1D. Researchers found that children whose gut microbiome followed one development pattern had around three times the risk of developing type 1, or early immune changes linked to the condition, compared with children in another group.
The team analysed more than 12,000 stool samples collected during the children’s first six years of life. This helped them see how each child’s gut microbiome changed over time.
They identified three broad patterns of microbiome development: Early Matured, Late Matured and Early Plateaued.
Children whose microbiomes followed the Early Plateaued pattern had around three times the risk of developing T1D or the immune changes that can precede diagnosis, compared with those in the Early Matured group.
The study also suggests that genetic variations which subtly affect the way the immune system works may play a part. These different genes could affect how gut bacteria and T1D risk are connected.
Rachel Connor, Director of Research Partnerships at Breakthrough T1D, said:
“This study does not show that changes in gut bacteria cause type 1 diabetes, or that changing a child’s gut bacteria could prevent it. But it gives researchers an important new clue to investigate. Thanks to our supporters, we can fund long-term research that helps to build a clearer picture of how type 1 diabetes develops, and ultimately harness this knowledge to develop new ways to slow or stop T1D in its tracks.”
It is important to be careful about what this study means. It shows a link between gut bacteria and T1D risk. It does not prove that changes in gut bacteria cause it.
The children in the study all had a high genetic risk of T1D. More research is needed to understand whether the same findings apply to children with different levels of genetic risk.
It is also too early to know whether changing the gut microbiome could reduce the risk of T1D. Further studies would be needed to answer that question.
The findings add another piece to the puzzle of how genetics, the immune system and environmental factors like the microbiome may interact during the earliest stages of T1D.
Danyue Dong, researcher at Harvard Medical School and lead author of this paper, said
“Extending this work to intervention studies is very much a direction we would like to pursue. Promising approaches could include microbiome-targeted interventions such as dietary modification and targeted supplementation in people with increased genetic susceptibility to T1D. An important next question is whether these approaches can shift the microbial signatures we identified and, ultimately, influence progression to autoimmunity.”
Thanks to supporters like you, Breakthrough T1D can fund research that helps us understand type 1 diabetes and move closer to preventing and curing it.
Find out how early detection works, why it matters, and how you can access screening for yourself, your child or someone you care for.
Dealing with type 1 every day can have an emotional impact, whether you’re newly diagnosed or have been living with type 1 for some time.
Find out about our research to find cures for T1D and make everyday life better for those who face it.
We look at a new feature coming to the CamAPS FX app, which will allow users to remove the need to count carbohydrates before a meal.
In draft guidance published today, NICE recommends that anyone with type 1 diabetes who is pregnant or planning a pregnancy should be offered pregnancy-specific HCL technology.
Discussing the main themes from this year's Advanced Technologies & Treatments for Diabetes conference – early detection, cellular cures and disease-modifying therapies.
Highlights from an extraordinary year in type 1 diabetes (T1D) research, treatment, advocacy and policy.
Researchers from John Hopkins University, USA, partially funded by Breakthrough T1D, have developed an experimental treatment that protects the insulin-producing cells from inflammatory damage, allowing them to survive for longer in animal models.
Would you like to visit the website of our {{ affiliate_country }} affiliate to complete your action?